• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用血浆和尿液美沙酮浓度测量来限制美沙酮维持治疗患者的麻醉药品使用:II. 血浆浓度反应曲线的生成

Utilization of plasma and urine methadone concentration measurements to limit narcotics use in methadone maintenance patients: II. Generation of plasma concentration response curves.

作者信息

Kell M J

出版信息

J Addict Dis. 1995;14(1):85-108. doi: 10.1300/J069v14n01_09.

DOI:10.1300/J069v14n01_09
PMID:7632750
Abstract

Controversy exists still concerning the proper daily dose of methadone required to eliminate illicit narcotics use. To address this, urine methadone and opioid concentrations were measured prospectively (150 maintenance patients, 18 month period, 9250 urine samples) using fluorescence polarization immunoassay. Results demonstrate that current thresholds (EMIT uses 300 micrograms/L) defining opiate positive urines are overly high (FPIA can go as low as 25 micrograms/L), causing severe underestimation of opioid use in the typical clinic. Using this data, plasma methadone concentration and dose response probability curves were generated for illicit opiate use. Results demonstrate a S-shaped, 24 hr trough plasma methadone concentration response curve with effective concentrations, EC90 = 80 micrograms/L, EC98 = 600 micrograms/L. Plotting mean plasma methadone concentration versus dose gives a monotonically increasing function: Conc = 5.367*dose0.858, raw R-squared = 0.967, corrected R-squared = 0.802. Unfortunately, coefficients of variation for plasma concentrations at each prescribed dose are unacceptably large, explaining poor dose response relationships for some patients.

摘要

关于消除非法麻醉品使用所需美沙酮的适当每日剂量仍存在争议。为了解决这个问题,使用荧光偏振免疫分析法对尿液中美沙酮和阿片类药物浓度进行了前瞻性测量(150名维持治疗患者,为期18个月,9250份尿液样本)。结果表明,目前定义阿片类药物阳性尿液的阈值(EMIT法使用300微克/升)过高(荧光偏振免疫分析法低至25微克/升),导致典型诊所中阿片类药物使用情况被严重低估。利用这些数据,生成了非法阿片类药物使用的血浆美沙酮浓度和剂量反应概率曲线。结果显示出一条S形的24小时谷值血浆美沙酮浓度反应曲线,有效浓度为EC90 = 80微克/升,EC98 = 600微克/升。绘制平均血浆美沙酮浓度与剂量的关系图得出一个单调递增函数:浓度 = 5.367×剂量^0.858,原始决定系数R² = 0.967,校正决定系数R² = 0.802。不幸的是,每个规定剂量下血浆浓度的变异系数大得令人无法接受,这解释了一些患者剂量反应关系不佳的原因。

相似文献

1
Utilization of plasma and urine methadone concentration measurements to limit narcotics use in methadone maintenance patients: II. Generation of plasma concentration response curves.利用血浆和尿液美沙酮浓度测量来限制美沙酮维持治疗患者的麻醉药品使用:II. 血浆浓度反应曲线的生成
J Addict Dis. 1995;14(1):85-108. doi: 10.1300/J069v14n01_09.
2
Non-prescribed drug use during methadone treatment by clinic- and community-based patients.
Addiction. 1996 Nov;91(11):1699-704.
3
Utilization of plasma and urine methadone concentrations to optimize treatment in maintenance clinics: I. Measurement techniques for a clinical setting.
J Addict Dis. 1994;13(1):5-26. doi: 10.1300/J069v13n01_02.
4
Therapeutic thresholds in methadone maintenance treatment: a receiver operating characteristic analysis.
Drug Alcohol Depend. 2006 Feb 1;81(2):129-36. doi: 10.1016/j.drugalcdep.2005.06.005. Epub 2005 Jul 18.
5
Effect of saquinavir/ritonavir (1000/100 mg bid) on the pharmacokinetics of methadone in opiate-dependent HIV-negative patients on stable methadone maintenance therapy.沙奎那韦/利托那韦(1000/100毫克,每日两次)对接受稳定美沙酮维持治疗的阿片类药物依赖的HIV阴性患者美沙酮药代动力学的影响。
Addict Biol. 2009 Jul;14(3):321-7. doi: 10.1111/j.1369-1600.2009.00158.x.
6
Cocaine abuse sharply reduced in an effective methadone maintenance program.在一个有效的美沙酮维持治疗项目中,可卡因滥用现象大幅减少。
J Addict Dis. 1999;18(4):63-75. doi: 10.1300/J069v18n04_06.
7
Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships.美沙酮维持治疗患者的稳态药代动力学和药效学:有和没有经历戒断反应者的比较以及浓度-效应关系
Clin Pharmacol Ther. 1999 Jun;65(6):685-94. doi: 10.1016/S0009-9236(99)90090-5.
8
Opioid plasma concentrations in methadone-and buprenorphine-maintained patients.美沙酮和丁丙诺啡维持治疗患者的阿片类药物血浆浓度。
Addict Biol. 2005 Dec;10(4):365-71. doi: 10.1080/13556210500358441.
9
Correlation between high methadone doses and methadone serum levels in methadone maintenance treatment (MMT) patients.美沙酮维持治疗(MMT)患者中高剂量美沙酮与美沙酮血清水平的相关性。
J Addict Dis. 2007;26(1):15-26. doi: 10.1300/J069v26n01_03.
10
The use of levo-alpha-acetylmethadol (LAAM) in methadone patients who have not achieved heroin abstinence.在尚未实现戒除海洛因的美沙酮治疗患者中使用左旋-α-乙酰美沙朵(LAAM)。
J Addict Dis. 2002;21(3):13-22. doi: 10.1300/J069v21n03_02.

引用本文的文献

1
Methadone Concentrations in Exhaled Breath Condensate, Serum and Urine of Patients Under Maintenance Treatment.维持治疗患者呼出气冷凝物、血清和尿液中的美沙酮浓度
Iran J Pharm Res. 2017 Fall;16(4):1621-1630.
2
Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships of methadone in a sample of Iranian (mazandarani) opiate users undergoing methadone maintenance treatment.接受美沙酮维持治疗的伊朗(马赞德兰省)阿片类药物使用者样本中美沙酮的群体药代动力学及药代动力学-药效学关系
Iran J Psychiatry Behav Sci. 2011 Fall;5(2):53-61.
3
Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.
美沙酮临床药代动力学的个体间变异性:对阿片类药物依赖治疗的影响。
Clin Pharmacokinet. 2002;41(14):1153-93. doi: 10.2165/00003088-200241140-00003.
4
Glucuronidation of 3'-azido-3'-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid.人肝微粒体对3'-叠氮-3'-脱氧胸苷(齐多夫定)的葡萄糖醛酸化作用:与阿托伐醌、氟康唑、美沙酮和丙戊酸临床药代动力学相互作用的相关性
Antimicrob Agents Chemother. 1998 Jul;42(7):1592-6. doi: 10.1128/AAC.42.7.1592.